Audible Premium Plus. $0.99/mo for the first 3 months + $20 Audible credits. 12 days only. Get this deal. Cancel anytime.

Magenkrebs: Neuzulassung erweitert Therapiespektrum
Nov 26 2024
Length: 9 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Magenkrebs: Neuzulassung erweitert Therapiespektrum

Listen for free

View show details

Summary
Durchbruch in der Magenkrebstherapie? Dennis Ballwieser beleuchtet den neuen Wirkstoff Zolbetuximab.

Show more Show less

Show more Show less

What listeners say about Magenkrebs: Neuzulassung erweitert Therapiespektrum

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon